Title

Cardiovascular impact of coronavirus disease 2019 (Covid-19)

Document Type

Article

Publication Date

2-1-2021

Abstract

Coronavirus disease 2019 (COVID-19) is an infection caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Although COVID-19 primarily affects the respiratory system, it can also cause cardiovascular complications. Patients with pre-existing cardiovascular comorbidities are at risk for greater severity of illness and mortality. The cardiovascular effects of medications that may be used to treat COVID-19, as well as the impact of medications used for underlying cardiovascular conditions, are important considerations. Pharmacists should be aware of the potential cardiovascular impact of COVID-19.

This document is currently not available here.

Share

COinS